Find the latest news from Novozymes' news archive.
26. October 2012
The partners are entering into an exclusive global marketing and distribution agreement on a unique biofungicide used to combat damaging fungal diseases across a range of crops.
25. October 2012
Sales growth in DKK was 6% (2% LCY, 3% organic) compared with the first 9 months of 2011. EBIT grew by 12%, and the EBIT margin increased to 24.6%. The expectations for full-year 2012 EBIT growth, EBIT margin and net profit growth are maintained, as is the expectation for free cash flow.
19. September 2012
Funding for CleanStar Mozambique benefits smallholder farmers and the environment, creates jobs, and protects families from indoor air pollution
18. September 2012
Novozymes is the only company to receive P&G’s highest external business partner recognition – the ‘External Business Partner of the Year’ award – five years in a row.
13. September 2012
Novozymes is the most sustainable company in the "Biotechnology" sector as per the Dow Jones Sustainability Index 2012
5. September 2012
By working with transport companies, Novozymes succeeds at reducing traffic supplying the company's production site in Kalundborg by 800 fewer trucks, reducing CO2 emissions by 148 tons a year.
28. August 2012
C5 yeast is an essential component in the production of cellulosic ethanol, and the partnership will allow Novozymes to speed up global roll-out of Terranol’s yeast to customers in the cellulosic ethanol industry.
22. August 2012
Backed by a federal-private partnership and slated to open in 2014, the biorefinery will create 315 jobs and produce cost-competitive cellulosic ethanol from energy crops.
17. August 2012
Joint R&D cooperation to develop an industrial biotechnology-based production process for acrylic acid from renewable raw materials. Key raw material for the production of bio-based superabsorbents for baby diapers.
16. August 2012
Novozymes has developed a robust microorganism that enables efficient production of biobased malic acid. The technology makes it possible to produce plastic and other oil-derived products from renewable raw materials.
Sales growth in DKK was 7% (3% LCY, 3% organic) compared with the first half of 2011. EBIT grew by 12%, and the EBIT margin increased to 24.2%. The expectation for full-year 2012 EBIT growth is increased to 11-14% from 9-12%, and EBIT margin is now expected at 23-24%.
13. August 2012
Novozymes and the Holck-Larsen Foundation have come together along with Danish universities to set up first of its kind scientist exchange program between India and Denmark.
25. June 2012
New independent trials show that the enzyme Novozymes Acrylaway® can reduce acrylamide, a potential health risk, in french fries. Acrylaway has already been proven to reduce acrylamide in coffee, biscuits, crackers and other products.
15. June 2012
Shengquan is investing $100 million to produce cellulosic ethanol. Novozymes will supply the enabling enzyme technology. The two companies will sign the final agreement Friday during Hu Jintao’s visit to Denmark.
13. June 2012
Novozymes offers many solutions in sustainable industry and agriculture that are available today, in the areas of biofuels, plastics, agriculture, food, feed, textiles and more.
7. June 2012
Novozymes, the world leader in bioinnovation, opens a business and innovation center in the Shandong Province to further develop its leading position in industrial biotechnology in the Chinese market.
30. May 2012
Advanced biofuels took a $200 million step forward on the march toward commercialization today with the inauguration of Novozymes’ enzyme plant in Blair, Nebraska.
23. May 2012
Brazilian bioenergy company GraalBio to construct commercial scale cellulosic ethanol facility in Brazil by 2013. Novozymes looks to establish new enzyme manufacturing plants in Brazil and has begun search for possible locations.
17. May 2012
The biofuel manufacturing plant enables innovative food and household energy venture to improve family health, increase farmer incomes and nutrition, and protect Mozambique’s forests.
9. May 2012
Novozymes has started to supply Novozymes Hyasis, a novel pharmaceutical-grade hyaluronic acid, from its newly opened facility. The product targets medical device and pharmaceutical markets with an estimated volume of DKK 1 billion.
3. May 2012
In collaboration with the Danish Fashion Institute, Novozymes provides advice for UN Global Compact with the aim of creating sustainable change in the textile industry.
1. May 2012
Acceptance speech outlines the arguments for moving towards a biobased economy driven by science and innovation from industry and stable public policy.
26. April 2012
Novozymes and Maabjerg Energy Concept have entered into an agreement making Novozymes a partner in the consortium alongside national energy giant DONG Energy A/S and local utility companies Vestforsyning A/S, Struer Forsyning A/S and Nomi I/S.
25. April 2012
Novozymes and Syngenta announces a global agreement under which Syngenta will work with Novozymes to commercialize JumpStart technology, a seed-applied biological that increases phosphate solubilization in the soil.
Overall sales growth of 2% in DKK for Q1 2012 is in line with expectations, on the back of a challenging comparison in the first quarter of 2011. The outlook for sales growth is maintained at 7–11% in DKK and 4–8% organically.
| Copyright © 2010 Novozymes. All Rights Reserved.